CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cressman, V. L.
Right arrow Articles by Koller, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cressman, V. L.
Right arrow Articles by Koller, B. H.
Cell Growth & Differentiation Vol. 10, 1-10, January 1999
© 1999 American Association for Cancer Research

Mammary Tumor Formation in p53- and BRCA1-deficient Mice1

Victoria L. Cressman, Dana C. Backlund, Elizabeth M. Hicks, Lori C. Gowen, Virginia Godfrey and Beverly H. Koller2

Curriculum in Genetics and Molecular Biology [V. L. C., L. C. G.], and Departments of Pathology [V. G.] and Medicine [D. C. B., E. M. H., B. H. K.], University of North Carolina at Chapel Hill, Chapel Hill,North Carolina 27599

The inheritance of a mutant copy of the BRCA1 gene greatly increases a woman’s lifetime risk for ovarian and breast cancer. While a homologous gene has been identified in mouse, mice carrying mutations in this gene do not display a detectable increase in tumor formation. To determine whether mutations in p53 might increase the incidence of tumors associated with the loss of BRCA1 function in mice, we have generated mice carrying mutations at both of these loci. We report here that the presence of a mutant Brca1 allele does not alter survival of either p53-/- or p53+/- mice. Although the tumor spectrum was not dramatically altered, an increased incidence of mammary tumors was observed in the Brca1+/-p53-/- mice. Four mammary tumors were seen in the Brca1+/-p53-/- group whereas only one such tumor was seen among the p53-/- control group. In addition, although the presence of a mutant Brca1 allele did not alter the survival rate or the incidence of most tumor types in the p53+/- mice, 5 of the 23 tumors isolated from the Brca1+/-p53+/- mice treated with ionizing radiation were of mammary epithelial origin, and 3 of these had lost expression of the wild-type Brca1 gene. In contrast, no such tumors were observed in the irradiated p53+/- controls. Although the number of mammary tumors observed in these animals is small, these results are suggestive of a role for BRCA1 in mammary tumor formation after exposure to specific DNA damaging agents.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
K. C. Jackson, E.-K. Gidlund, J. Norrbom, A. P. Valencia, D. M. Thomson, R. A. Schuh, P. D. Neufer, and E. E. Spangenburg
BRCA1 is a novel regulator of metabolic function in skeletal muscle
J. Lipid Res., April 1, 2014; 55(4): 668 - 680.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb. Perspect. Biol.Home page
A. D. Borowsky
Choosing a Mouse Model: Experimental Biology in Context--The Utility and Limitations of Mouse Models of Breast Cancer
Cold Spring Harb Perspect Biol, September 1, 2011; 3(9): a009670 - a009670.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. W. Haines, M. R. Coster, J. Adam, M. Cheeseman, E. A. Ainsbury, J. Thacker, and S. D. Bouffler
Xrcc2 Modulates Spontaneous and Radiation-Induced Tumorigenesis in Apcmin/+ Mice
Mol. Cancer Res., September 1, 2010; 8(9): 1227 - 1233.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Houghtaling, L. Granville, Y. Akkari, Y. Torimaru, S. Olson, M. Finegold, and M. Grompe
Heterozygosity for p53 (Trp53+/-) Accelerates Epithelial Tumor Formation in Fanconi Anemia Complementation Group D2 (Fancd2) Knockout Mice
Cancer Res., January 1, 2005; 65(1): 85 - 91.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C.-M. Chen and R. R. Behringer
Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis
Genes & Dev., February 1, 2004; 18(3): 320 - 332.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. O. Ward, L. G. Reinholdt, S. A. Hartford, L. A. Wilson, R. J. Munroe, K. J. Schimenti, B. J. Libby, M. O'Brien, J. K. Pendola, J. Eppig, et al.
Toward the Genetics of Mammalian Reproduction: Induction and Mapping of Gametogenesis Mutants in Mice
Biol Reprod, November 1, 2003; 69(5): 1615 - 1625.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. K. MacLachlan, R. Takimoto, and W. S. El-Deiry
BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair Targets
Mol. Cell. Biol., June 15, 2002; 22(12): 4280 - 4292.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Ueda, S. Kurebayashi, M. Sakaue, M. Backlund, B. Koller, and A. M. Jetten
High Incidence of T-Cell Lymphomas in Mice Deficient in the Retinoid-related Orphan Receptor ROR{gamma}
Cancer Res., February 1, 2002; 62(3): 901 - 909.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. R. Venkitaraman
Functions of BRCA1 and BRCA2 in the biological response to DNA damage
J. Cell Sci., October 15, 2001; 114(20): 3591 - 3598.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. G. Backlund, S. L. Trasti, D. C. Backlund, V. L. Cressman, V. Godfrey, and B. H. Koller
Impact of Ionizing Radiation and Genetic Background on Mammary Tumorigenesis in p53-deficient Mice
Cancer Res., September 1, 2001; 61(17): 6577 - 6582.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. M. Bennett, K. A. McAllister, J. Malphurs, T. Ward, N. K. Collins, J. C. Seely, L. C. Gowen, B. H. Koller, B. J. Davis, and R. W. Wiseman
Mice Heterozygous for a Brca1 or Brca2 Mutation Display Distinct Mammary Gland and Ovarian Phenotypes in Response to Diethylstilbestrol
Cancer Res., July 1, 2000; 60(13): 3461 - 3469.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
V. L. Cressman, D. C. Backlund, A. V. Avrutskaya, S. A. Leadon, V. Godfrey, and B. H. Koller
Growth Retardation, DNA Repair Defects, and Lack of Spermatogenesis in BRCA1-Deficient Mice
Mol. Cell. Biol., October 1, 1999; 19(10): 7061 - 7075.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1999 by the American Association of Cancer Research.